Member Exclusive

Webinar Q and A follow-up: ‘Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial’

Follow-up of the live webinar Q and A session

Go to the profile of RegMedNet
May 20, 2015

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.